Diagnostic and Prognostic Value of Serial Procalcitonin (PCT) Measurements in Critically Ill Patients (PCT)
Diagnostic and Prognostic Value of Serial PCT Measurements in Critically Ill Patients
研究概览
地位
条件
详细说明
Procalcitonin (PCT) is a 116 amino acid peptide that has an approximate MW of 14.5 kDa and belongs to the calcitonin (CT) superfamily of peptides. Transcription of the CALC-1 gene for PCT is usually suppressed in the non-neuroendocrine tissue, except in the C cells of the thyroid gland where its expression produces PCT, the precursor of CT in healthy individuals and in the absence of infection.
In the presence of microbial infection, circulating levels of calcitonin precursors (CTpr), including PCT, increase up to several thousand-fold.1 In addition to being a marker of microbial infection, PCT also acts as a modulator of the host inflammatory reaction. In an animal model of sepsis, administration of exogenous human PCT worsened outcome, whereas neutralization of endogenous PCT improved survival.
There are several inflammatory laboratory markers, like tumor necrosis factor (TNF)-α, interleukin (IL)-1, IL-6 and C-reactive protein (CRP), but they are non- specific for infection and can be caused by conditions like pancreatitis, burns, trauma or acute lung injury. The non-specific nature of clinical and laboratory parameters for microbial infection makes it difficult to evaluate patients with potential infection. In addition to the lack of specificity, traditional laboratory and clinical indicators of sepsis are not temporally concordant with the course of illness. As a result, these tests are not reliable to evaluate the response to therapeutic interventions in real time.
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
Ohio
-
Cleveland、Ohio、美国、44195
- Cleveland Clinic
-
-
参与标准
资格标准
适合学习的年龄
- 孩子
- 成人
- 年长者
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- All consecutive patients admitted to the Medical Intensive Care Unit of the Cleveland Clinic with an anticipated MICU stay of ≥ 12hrs
Exclusion Criteria:
- Age less than 18-years of age and/or an expected MICU stay of less than 12-hrs
学习计划
研究是如何设计的?
设计细节
- 观测模型:病例对照
- 时间观点:预期
队列和干预
团体/队列 |
|---|
|
Sepsis or Septic shock cohort
|
|
Non-sepsis or non-Septic shock cohort
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Development of organ failure
大体时间:Current hospitalization (participants will be followed for the duration of hospital stay; an expected average of 7-days)
|
Current hospitalization (participants will be followed for the duration of hospital stay; an expected average of 7-days)
|
|
Development and resolution of shock using a cut-off PCT of >0.5ng/mL
大体时间:ICU stay (participants will be followed for the duration of hospital stay; an expected average of 7-days)
|
ICU stay (participants will be followed for the duration of hospital stay; an expected average of 7-days)
|
|
ICU and Hospital Mortality
大体时间:current hospitalization or 28-day post ICU admission for ICU survivors
|
current hospitalization or 28-day post ICU admission for ICU survivors
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Development of hospital acquired infections (catheter related blood stream infection, development of multidrug resistant infections, ventilator associated pneumonia)
大体时间:Current hospitalization (participants will be followed for the duration of hospital stay; an expected average of 7-days)
|
Current hospitalization (participants will be followed for the duration of hospital stay; an expected average of 7-days)
|
合作者和调查者
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.